Your browser doesn't support javascript.
loading
Advances in the Research on Anticardiolipin Antibody.
Wang, Dan; Lv, Wenxin; Zhang, Shichang; Zhang, Jiexin.
Affiliation
  • Wang D; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
  • Lv W; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
  • Zhang S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
  • Zhang J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
J Immunol Res ; 2019: 8380214, 2019.
Article in En | MEDLINE | ID: mdl-31886311
ABSTRACT
Anticardiolipin antibody (ACA) is a kind of autoantibody and is one of the antiphospholipid antibodies (aPLs). Phospholipids with a negative charge on platelets and endothelial cell membranes are ACA target antigens. ACA is common in systemic lupus erythematosus and other autoimmune diseases and is closely associated with thrombosis, thrombocytopenia, and spontaneous abortion. In 1983, Harris established a method for detecting ACA, and research on the antibody has gained worldwide attention and has developed rapidly. For this review, we browsed articles that cover most of the ACA-related studies in the last 25 years and extracted influential ideas and conclusions in this field.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Autoantigens / Autoimmune Diseases / Cardiolipins / Antibodies, Anticardiolipin / Disease Susceptibility Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Immunol Res Year: 2019 Document type: Article Affiliation country: China Publication country: EG / EGIPTO / EGITO / EGYPT

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Autoantigens / Autoimmune Diseases / Cardiolipins / Antibodies, Anticardiolipin / Disease Susceptibility Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Immunol Res Year: 2019 Document type: Article Affiliation country: China Publication country: EG / EGIPTO / EGITO / EGYPT